These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9814683)

  • 1. Anti-beta2-glycoprotein I antibodies.
    Tsutsumi A; Ichikawa K; Matsuura E; Koike T
    Lupus; 1998; 7 Suppl 2():S98-102. PubMed ID: 9814683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus.
    Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Koike T
    J Rheumatol; 1998 Jan; 25(1):74-8. PubMed ID: 9458206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
    Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I.
    Tsutsumi A; Ichikawa K; Matsuura E; Sawada KI; Koike T
    J Rheumatol; 2000 Feb; 27(2):391-6. PubMed ID: 10685803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.
    Schlame M; Haller I; Sammaritano LR; Blanck TJ
    Thromb Haemost; 2001 Dec; 86(6):1475-82. PubMed ID: 11776316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of high-avidity anti-beta2-glycoprotein I antibodies.
    Cucnik S; Kveder T; Rozman B; Bozic B
    Rheumatology (Oxford); 2004 Nov; 43(11):1353-6. PubMed ID: 15280573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells.
    Caronti B; Calderaro C; Alessandri C; Conti F; Tinghino R; Pini C; Palladini G; Valesini G
    J Autoimmun; 1998 Oct; 11(5):425-9. PubMed ID: 9802925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
    Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
    J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
    Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
    J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG; Baranov NG; Nasonov EL
    Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.